| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Vor Biopharma Inc (NASDAQ: VOR)
VOR Technical Analysis
5
| As on 16th May 2025 VOR SHARE Price closed @ 0.18 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.56 & Strong Sell for SHORT-TERM with Stoploss of 2.25 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VORSHARE Price
| Open | 0.17 | Change | Price | % |
| High | 0.27 | 1 Day | 0.01 | 5.88 |
| Low | 0.16 | 1 Week | -0.36 | -66.67 |
| Close | 0.18 | 1 Month | -0.41 | -69.49 |
| Volume | 50079563 | 1 Year | -1.66 | -90.22 |
| 52 Week High 2.85 | 52 Week Low 0.15 | ||||
NASDAQ USA Most Active Stocks
| AFMD | 0.28 | 211.11% |
| AMRS | 0.14 | 100.00% |
| HCTI | 0.01 | -75.00% |
| BON | 0.06 | 20.00% |
| PLUG | 0.77 | 10.00% |
| NVDA | 135.40 | 0.42% |
| AGMH | 0.07 | 16.67% |
| GNLN | 0.01 | 0.00% |
| LCID | 2.84 | 5.58% |
| LMDX | 0.02 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| VOR Daily Charts |
VOR Intraday Charts |
Whats New @ Bazaartrend |
VOR Free Analysis |
|
|
VOR Important Levels Intraday
| RESISTANCE | 0.39 |
| RESISTANCE | 0.32 |
| RESISTANCE | 0.28 |
| RESISTANCE | 0.24 |
| SUPPORT | 0.12 |
| SUPPORT | 0.08 |
| SUPPORT | 0.04 |
| SUPPORT | -0.03 |
VOR Forecast May 2025
| 4th UP Forecast | 2.59 |
| 3rd UP Forecast | 1.82 |
| 2nd UP Forecast | 1.34 |
| 1st UP Forecast | 0.86 |
| 1st DOWN Forecast | -0.5 |
| 2nd DOWN Forecast | -0.98 |
| 3rd DOWN Forecast | -1.46 |
| 4th DOWN Forecast | -2.23 |
VOR Weekly Forecast
| 4th UP Forecast | 1.32 |
| 3rd UP Forecast | 0.95 |
| 2nd UP Forecast | 0.73 |
| 1st UP Forecast | 0.50 |
| 1st DOWN Forecast | -0.14 |
| 2nd DOWN Forecast | -0.37 |
| 3rd DOWN Forecast | -0.59 |
| 4th DOWN Forecast | -0.96 |
VOR Forecast2025
| 4th UP Forecast | 5.98 |
| 3rd UP Forecast | 4.12 |
| 2nd UP Forecast | 2.97 |
| 1st UP Forecast | 1.82 |
| 1st DOWN Forecast | -1.46 |
| 2nd DOWN Forecast | -2.61 |
| 3rd DOWN Forecast | -3.76 |
| 4th DOWN Forecast | -5.62 |
Vor Biopharma Inc ( NASDAQ USA Symbol : VOR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VOR Business Profile
Vor Biopharma, Inc., early-stage cell therapy company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: 100 Cambridgepark Drive, Cambridge, MA, United States, 02140
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service